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Bone marrowBone marrow abnormalities are frequently observed in individuals with AIDS. Dysplasia, the most common ab-
normality, is found inmore than 50% of patients infectedwith the HIV. The aim of this studywas to assess trabec-
ular thickness and collagen content as well as cellularity in the bone marrow of patients with AIDS. Sixty bone
marrow sampleswere collected from the sternumof autopsied patientswith orwithout AIDS (n=30, each). Cel-
lularity and trabecular thickness was assessed by performing hematoxylin-eosin staining; picrosirius staining
was used to evaluate collagen content. Morphometric analyses were performed by using a Zeiss KS300 system
(Kontron-Zeiss). Patients with AIDS showed a signiﬁcant reduction in trabecular bone thickness and an increase
in collagen deposition. No statistically signiﬁcant differences were observed in cellularity between the 2 groups.
Therefore, reduced thickness and increased collagen depositionwere observed in the trabeculae of the bonemar-
row of patients with AIDS due to possible interaction between cytokines and bone marrow components.mento Cientíﬁco e Tecnológico
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The AIDS is a systemic disease with multiple complications. Bone
marrow abnormalities are observed in all stages of HIV infection, and
their frequency increaseswith disease progression [1]. Lowboneminer-
al density and a decreased bone mass have been reported in male and
female HIV-infected patients of several ages [2,3].
HIV infection may compromise hematopoiesis by directly infecting
progenitor cells or by causing changes in the bone marrow microenvi-
ronment, whichmay affect its ability to support proliferation and differ-
entiation of progenitor cells [4]. The investigation of the bone marrow
healthy is important in patients with peripheral hematological abnor-
malities. Anemia is present in most of HIV infected symptomatic like
normocytic normochromic anemia or anemia of chronic disease [5].
HIV is able to infect a variety of stromal elements of the bonemarrow,
including monocytes and macrophages, endothelial and myoepithelialcells, and ﬁbroblasts [6–8]. Previous studies have shown that increased
bone marrow ﬁbrosis is commonly observed in patients with HIV/
AIDS; however, the relationship between this deposition and CD4
T-lymphocyte counts remains controversial [9].
Osteoporosis was three-fold more prevalent in individuals infected
with HIV compared to non-infected individuals. The chronic inﬂamma-
tion caused by the virus has been associated with bone resorption and
osteoclast activity [3]. Moreover, anti-retroviral therapy has been corre-
lated with changes in bone metabolism, which render patients more
susceptible to osteopenia and osteoporosis [10].
Because histopathological studies of bone marrow from autopsied
patients with AIDS are rare, the aim of this studywas to analyze the tra-
becular thickness, percentage of collagen in the trabeculae, and bone
marrow cellularity in autopsied patients with AIDS. The results of this
study provide a scientiﬁc basis for understanding this microenviron-
ment better, whichwill support the development of therapies to reduce
bone changes during HIV infection.
2. Materials and methods
This studywas approved by the TriânguloMineiro Federal University
Research Ethics Committee, approval number 850.
Sixty bonemarrow samples were collected from the middle third of
the sternum during autopsies performed at the Clinical Hospital at the
Triângulo Mineiro Federal University, Uberaba, Minas Gerais, Brazil,
being a retrospective study that occurred between 1983 and 2007.
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vision of Clinical Hospital at the Triângulo Mineiro Federal University
which is responsible for autopsies. From those reports were obtained
data such as age, gender, skin color, and bodymass index (BMI). The pa-
tients were divided into 2 groups: with AIDS (n= 30) or without AIDS
(n = 30). The control group was selected with the attempt to pair age,
gender, and race with the group of patients with AIDS.
AIDS diagnosis was conﬁrmed by evidence of at least one AIDS-
deﬁning disease presented by the patient and by CD4 T lymphocyte
count below 200 cells/mm3 [11,12]. Inclusion criteria for AIDS patients
were deﬁned as those who owned at least one of the following deﬁning
diseases: invasive cervical cancer, extrapulmonary cryptococcosis, Her-
pes simplex mucocutaneous, or non-Hodgkin lymphoma [13]. All the
patients with AIDS observed in this study died of infection during the
post- HAART era. However, not all of them hadmade use of the therapy,
whichmay be explained by the fact thatmany of them looked for health
services in an advanced stage of the disease. Opportunistic infections
were not considered in the selection of patients. There were no exclu-
sion criteria.
Bone marrow fragments were subjected to histological processing,
and serial 4-μm thick sections were cut. Cellularity (hypercellularity,
normality, or hypocellularity) was assessed by observing hematoxylin-
eosin (HE) stained slides under an objective lens with a magniﬁcation
power of 5× (ﬁnal magniﬁcation ×200). To evaluate trabecular thick-
ness, slides stained with HE were observed under an objective lens
with a magniﬁcation power of 20× (ﬁnal magniﬁcation ×800); the
thickness was expressed in micrometers (μm). To obtain these mea-
sures, each histological section was divided into 4 ﬁelds, and 5 trabecu-
laewere randomly selected in each ﬁeld. In each trabecula, 5 minor axis
measurements (100 measurements per slide) were performed, deter-
mined by the accumulated mean method [14].
Picrosirius stained slides were used to quantify collagen expression
in the trabecular bones. Histological sections were analyzed under po-
larized light with an objective lens having a magniﬁcation power of
5× (ﬁnal magniﬁcation ×200). Collagen deposition, quantiﬁed by the
observer, presented as birefringence with orange to red shading. Ten
trabeculae from each of the 4 ﬁelds per histological section were ana-
lyzed, with a total of 40 measurements per slide. Collagen percentage
and trabecular thickness were quantiﬁed by using a video camera
coupled to a common light microscope and an image analysis system
(KS300 – Kontron Zeiss). Taking these criteria into account, these mea-
surements were made by a researcher individually.
Statistical analyses were performed by using the SigmaStat software
suite. After applying the Kolmogorov-Smirnov test, the Student t test
was used in case of normal distribution and similar variances; the
Mann-Whitney U test (T) was used to analyze non-parametric distribu-
tions. Correlations were analyzed by using the Pearson (r) and Spear-
man (rS) tests. Differences in probability (P) lower than 5% (P b .05)
were considered statistically signiﬁcant.
3. Results
Sixty bonemarrow samples were collected from autopsied patients.
The average age of patients with or without AIDS was 31.86 ± 7.59Table 1
Constitutional and morphometric data from bone marrow of autopsied patients with or witho
Group n (%) AgeI (years) BMIII (k
X± SD or Med (Min –Max)
With AIDS 30 (50) 31.86 ± 7.59 20.43 ±
Without AIDS 30 (50) 48.73 ± 16.44 25.21 ±
Total 60 (100)
I t= 5.100; P b .0001.
II t= 3.474; P= .001.
III t= 3328000; P b .0001.
IV t= 507400; P b .0001.years and 48.73 ± 16.44 years, respectively, and the BMI of patients
with and without AIDS was 20.43 ± 4.14 kg/m2 and 25.21 ± 6.45 kg/m2,
respectively (Table 1). At the AIDS group, 7 patients were female
(23.33%) and 23 were male (76.66%); 25 were white (83.33%) and 5
were nonwhite (16.66%). At the without-AIDS group, 11 patients were
female (36.66%) and 19 were male (63.33%); 24 were white (80%)
and 6 nonwhite (20%).
Patients with AIDS showed signiﬁcantly reduced trabecular bone
thickness (Table 1). A signiﬁcant positive correlation was observed be-
tween the trabecular bone thickness and age of patients with AIDS
(rS = 0.0349; P= .006), and a signiﬁcant negative correlation was ob-
served between the trabecular thickness and BMI in the same patient
group (rS =−0.156; P b .001).
The percentage of collagen ﬁbers in the trabecular bone was signiﬁ-
cantly higher in patients with AIDS (Fig. 1, Table 1). A negative and sta-
tistically non-signiﬁcant correlation was observed between the
percentage of collagen ﬁbers and the age of patients with AIDS (rS =
−0.0107; P= .600), and a negative and statistically signiﬁcant correla-
tion was observed between collagen percentage and BMI in the same
patient group (rS =−0.024; P b .001).
No signiﬁcant differences the bonemarrow cellularity of patients be-
tween the 2 groups (Fig. 2).
4. Study limitations
As this study was conducted using data collected from autopsy re-
ports, many relevant information for the bone health it cannot be ob-
tained, such as smoking, menopause, use of hormone therapy, use of
antiretroviral therapy, CD4 count and viral load at the time of death,
among other factors that possibly inﬂuence bone formation. A cross-
sectional study conducted in São Paulo (Brazil), which included 4.332
women over 40 years who were treated in primary care service, ob-
served the prevalence of osteoporosis (33%) and osteoporotic fractures
(11.5%) in these patients [15]. Hypoestrogenism is considered an impor-
tant risk factor for low bonemineral density and recent studies correlat-
ed the occurrence of osteoporosis with the time of menopause. The
same reasoning applies to the use of hormone therapy for prevention
of osteoporosis. The beneﬁcial effects of estrogen therapy on the preser-
vation of BMI and reduce the risk of fractures are well established in the
literature [16]. A World Health Organization study indicated that
smoking confers substantial risk for future fracture, regardless of a
BMI [17]. Researchers have shown that individuals with low CD4 levels
have low bone mineral density; antiretroviral therapy affects the bone
structure as leads to a recovery of bone turnover [18].
5. Discussion
The changes of the bone marrow have been the subject of several
studies in patients with HIV/AIDS. Its different constituents, such as tra-
becular bone, collagen ﬁbers, and cellularity show up in the affected
syndrome, as shown in Table 2.
In this study, patients with AIDS had signiﬁcantly reduced trabecular
bone thickness. Another study showed that the prevalence of
osteopenia and osteoporosis is 3-fold higher in patients infected withut AIDS
g/m2) Trabecular thicknessIII (μm) Collagen ﬁbersIV(%)
4.14 71.04 ± 26.32 6.14 ± 3.36
6.45 88.58 ± 28.77 4.73 ± 3.17
A B
C D
Fig. 1. Trabecular bone from patients without AIDS (A and B) and with AIDS (C and D), after performing hematoxylin and eosin staining (A and C) and picrosirius staining (B and
D) observed with polarized light under an objective lens with a magniﬁcation of 20×.
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for these changes are still not completely understood. However, chronic
inﬂammation caused by HIV infectionwas associatedwith bone resorp-
tion, and the virus itself may also directly affect osteoclast activi-
ty [19,20]. HIV Tat, a regulatory protein of viral transcription, has been
found to increase differentiation of precursor cells into osteoclast [21].
Tat viral protein was associated with increased osteoclast activity for-
mation by 70%, HIV Tat being biologically active in driving a pro-
osteoclastic phenotype [22]. The balance between bone formation and
reabsorption becomes progressively negative with aging, and most of
bone loss occurs after the age of 65 years, which is more intense in
women due to the drop of estrogen levels [23]. However, a signiﬁcant
proportion of trabecular bone loss throughout life is age related and
estrogen independent, since trabecular bone is not as sensitive to the
estrogen effects in maintaining bone mass as the cortical bone [24,25].
Some studies indicate that oxidative stress, which increases with
aging and is accentuated by sex steroid deﬁciency, may be an important
factor leading to impaired bone formation with aging [24]. The balance
between bone formation and resorption becomes increasingly negative
with increasing age, and most of the bone loss occurs after 65 years of
age and is actually more intense in women due to the sudden drop inA
Fig. 2. Bone marrow cellularity of patients with AIDS. A, Hypercellularity, Hestrogen levels [23]; however, a signiﬁcant proportion of trabecular
bone loss is directly related to age, regardless of estrogen levels; this is
because the trabecular bone does not have the same sensitivity to estro-
gen in terms of bone mass maintenance purposes, as with the cortical
bone [24,25]. Some studies suggest that increased oxidative stress,
which occurs with aging and is marked by a deﬁciency of sex steroids,
may be an important cause of poor bone formation [25].
Collagen deposition in trabecular bones was signiﬁcantly higher in
patients with AIDS and was more pronounced in younger patients and
those with lower BMI. Mature osteoblasts synthesize molecules in-
volved in bone formation or regulation of osteoclast activity, such as col-
lagen type I. These osteoblasts may be infected with HIV and directly
affected by viral replication [26]. Some studies have shown that low
body weight contributes to low bone mineral density, besides increas-
ing the risk of fracture, especially in older women. Increased peripheral
conversion of gonadal hormones in obese patients improve themainte-
nance of bone mass, protecting against the adverse effects of estrogen
deﬁciency on the skeleton [16]. BMI lower than 25 kg/m2 was associat-
ed with a 3-fold increase in the risk of developing osteoporosis and the
protective effect of body weight or BMI on bone has previously been re-
ported. The conversion of androgens to estrogens is an important sourceB
E staining. B, Hypocellularity, HE staining (original magniﬁcation ×5).
Table 2
Previously published studies on bone trabecula, ﬁbrosis, and bone marrow cellularity of
AIDS patients
Author Publication
year
Results
Osborne, Guarda
and Butler [41]
1984 Bone marrow damage, as evidenced by
hypocellularity, serous atrophy of the adipose
tissue, and prominent plasma cells, was present
in 22% biopsy specimens.
Geller et al [42] 1985 Evidenced distinctive pattern of hypercellularity
and ﬁbrosis in bone marrow smears
Castella et al [43] 1985 Reviewed 49 bonemarrow biopsies from AIDS
patients showed that 87% percent were normocellular
or hypercellular, and 17% were hypocellular
Donald et al [44] 1991 Study showed marrow hyper cellularity 52%
patients, hypocellularity in 13% patients.
Serrano et al [45] 1995 Histomorphometric analysis of the iliac crest
from22 HIV-infected demonstrated signiﬁcantly
lower bone turnover in these individuals in
comparison with a control group of healthy
kidney donors. In addition, bone formation at the
level of individual bone multicellular unit was
signiﬁcantly reduced, indicating reduced
osteoblastic activity.
Brown and
Qaqish [46]
2006 This study demonstrated a more than three-fold
greater prevalence of osteoporosis in HIV-infected
individuals compared with noninfected controls.
Calmy et al [47] 2013 This authors reported signiﬁcantly lower tibial
trabecular density and trabecular number, and
signiﬁcantly decreased radial cortical density in
22 HIV-infected premenopausal women
compared with age-matched controls.
Kotwal et al [48] 2013 Focal ﬁbrosis was seen in 25% of cases and 67.3%
of the patients showed normocellular marrow.
Biver et al [49] 2014 The trabecular network was disorganized with a
lower trabecular number or thickness and higher
heterogeneity in trabecular spacing; cortical area
was decreased, especially because of thinner cortex.
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and the local concentration of estradiol seems to contribute signiﬁcantly
to skeletal homeostasis. Collagen loss plays a major role in the patho-
genesis of osteoporosis. It has been postulated previously that hormone
reposition therapy in menopause leads to an increase in bone mass
by an increase in the collagen levels in bone, by elevating estrogen
levels [27,28].
Although this study did not observe a signiﬁcant change in cellular-
ity, a variety of nonspeciﬁc morphological abnormalities may be ob-
served microscopically in the bone marrow of patients infected with
HIV. Global hypercellularity may occur in the initial course of AIDS or
during systemic infections because of cellular hyperplasia of granulo-
cyte lineages and megakaryocytes. Increased hypocellularity and adi-
pose tissue atrophy have been observed as consequences of the
debilitation that occurs in later stages of AIDS [29,30].
Anatomically, the spaces in the bone marrow are compartmental-
ized, allowing immune and bone cells to interact and inﬂuence each
other. Therefore, bone homeostasis is often inﬂuenced by immune re-
sponses, particularly when the immune system is activated or compro-
mised [1]. Increasing evidence indicates that bone marrow suppression
is caused by viral infection of accessory cells, which results in impair-
ment of stromal function and an altered hematopoietic growth factor
network [31].
In this study, the bone marrow of patients with AIDS showed thin-
ning and increased collagen deposition in trabecular bone. The bone
marrow stroma consists of a mixture of cellular and extracellular com-
ponents, namely ﬁbroblasts, adipocytes, endothelial cells, macrophages,
adhesion molecules, and growth factors and, when amended, contrib-
utes to the development of hematological abnormalities in patients
with HIV/AIDS [32,33]. Fibroblasts are an important source of trophic
factors or inhibitory regulating the development of hematopoietic
progenitor cells. Direct infection of stromal components such asmacrophages, megakaryocytes, and ﬁbroblasts convert these cells into
HIV reservoirs and inhibit their ability to support growth of hematopoi-
etic progenitor cells [32–34].
Infection of these cells can result in deregulated expression of adhe-
sion molecules and regulatory cytokines and play an important role in
the development of cytopenias and susceptibility to infections [35,36].
Immune dysfunction in HIV-infected individuals are primarily due to
high levels inﬂammatory cytokines such as TNF-α, IFN-α, IFN-γ, and
TGF-β, which are present in bone marrow biopsies and serum of pa-
tients with the syndrome [37].
Previous experimental studies on HIV/AIDS have shown that colla-
gen production and pathological deposition were associated with
early induction of immunoregulatory response in secondary lymphoid
tissues consisted of regulatory T cells as well as other types of cells ex-
pressing TGF-β [38], suggesting that this cytokine is an important pro-
ﬁbrotic signal from HIV/AIDS disease.
Some authors also show a statistical correlation between CD41 lym-
phocyte count and the degree of reticulin ﬁbrosis, indicating that the
mechanism of bone marrow ﬁbrosis is independent of the disease
state [39,40].
In these patients, abnormalities are often observed in all bone mar-
row cells, including the matrix. It is hoped that this study contribute
to further studies that could demonstrate the relationship of bone
marrow changes with the immune and nutritional status of patients in-
fected with HIV and the presence of opportunistic infections. The inter-
pretation of the evaluated parameters in this study can be very helpful
in the diagnosis of conditions associated with HIV infection, contribut-
ing to clinical improvement and life expectancy of the patient.
References
[1] Tripathi AK, Misra R, Kalra P, Gupta N, Ahmad R. Bone marrow abnormalities in HIV
diseases. J Assoc Physicians India 2005;53:705–10.
[2] Jacobson DL, Lindsey JC, Gordon CM, Moye J, Hardin DS, Mulligan K, et al. Total body
and spinal bone mineral density across Tanner stage in perinatally HIV-infected and
uninfected children and youth in PACTG 1045. AIDS 2010;24(5):687–96.
[3] Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and
osteoporosis: a meta-analytic review. AIDS 2006;20(17):2165–74.
[4] Scadden DT, Zeira M, Woon A, Wang Z, Schieve L, Ikeuchi K, et al. Human immuno-
deﬁciency virus infection of human bone marrow stromal ﬁbroblasts. Blood 1990;
76(2):317–22.
[5] Kotwal J, Singh V, Kotwal A, Dutta V, Nair V. A study of haematological and bone
marrow changes in symptomatic patients with human immune deﬁciency virus in-
fection with special mention of functional iron deﬁciency, anaemia of critically ill
and haemophagocytic lymphohistiocytosis. Med J Armed Forces India 2013;69(4):
319–25.
[6] Gill V, Shattock RJ, Scopes J, Hayes P, Freedman AR, Grifﬁn GE, et al. Human immu-
nodeﬁciency virus infection impairs hemopoiesis in long-term bone marrow cul-
tures: nonreversal by nucleoside analogues. J Infect Dis 1997;176:1510–6.
[7] Kulkosky J, BouhamdanM, Geist A, Nunnari G, Phinney DG, Pomerantz RJ. Pathogen-
esis of HIV-1 infection within bone marrow cells. Leuk Lymphoma 2000;37:
497–515.
[8] Moses AV, Williams S, Heneveld ML, Strussenberg J, Rarick M, Loveless M, et al.
Human immunodeﬁciency virus infection of bone marrow endothelium reduces in-
duction of stromal hematopoietic growth factors. Blood 1996;87:919–25.
[9] WalshMC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, et al. Osteoimmunology: inter-
play between the immune system and bone metabolism. Annu Rev Immunol 2005;
24:33–63.
[10] Rey D, TregerM, Sibilia J, Priester M, Bernard-Henry C, Cheneau C, et al. Bonemineral
density changes after 2 years of ARV treatment, compared to naive HIV-1-infected
patients not on HAART. Scand J Infect Dis 2014;26:1–8.
[11] Wilkins BS, O'Brien CJ. Techniques for obtaining differential cell counts from bone
marrow trephine biopsy specimens. J Clin Pathol 1988;41(5):558-56.
[12] WHO. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case deﬁnitions for
surveillance. African Region: WHO; 2005.
[13] Brazil, Ministry of Health, Department of Health Care, National STD Control/AIDS
Program. Deﬁning criteria of AIDS cases in adults and children. Brasilia: Ministry
of Health; 2004.
[14] Williams MA. Quantitative methods in biology. In: Glauert AM, editor. Practical
Methods in Electron Microscope Analysis. Part II, vol. 6. Amsterdam: Elsevier;
1977. p. 36–8.
[15] Pinheiro MM, dos Reis Neto ET, Machado FS, Omura F, Yang JHK, Szejnfeld J, et al.
Risk factors for osteoporotic fractures and low bone density in women in pre and
post menopausal. Rev Saude Publica 2010;44:479-8.
[16] Buttros DAB, Nahas-Neto J, Nahas EAP, Cangussu LM, Barral ABCR, Kawakami MS.
Risk factors for osteoporosis in southeastern Brazil post menopausal. Rev Bras
Ginecol Obstet 2011;33(6):295–302.
413N.F.R. Dias et al. / Annals of Diagnostic Pathology 19 (2015) 409–413[17] Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, et al. Smoking and
fracture risk: a meta-analysis. Osteoporos Int 2005;16(2):155–62.
[18] Carvalho EH, Gelenske T, Bandeira F, Albuquerque MFPM. Bone mineral density in
women infected by HIV and treated with antiretroviral therapy: a systematic re-
view. Arq Bras Endocrinol Metabol 2010;54(2):133–42.
[19] Weitzmann MN. The role of inﬂammatory cytokines, the RANKL/OPG axis, and the
immunoskeletal interface in physiological bone turnover and osteoporosis.
Scientiﬁca (Cairo) 2013:125705.
[20] Rocha LP, Silva ATME, Gomes NC, Faria HA, Silva RB, Olegario JGP, et al. The inﬂuence
of gender and of AIDS on the immunity of autopsied patients' esophagus. AIDS Res
Hum Retroviruses 2011;27:511–8.
[21] Gibellini D, De Crignis E, Ponti C, Borderi M, Clò A, Miserocchi A, et al. HIV-1 Tat pro-
tein enhances RANKL/M-CSF-mediated osteoclast differentiation. Biochem Biophys
Res Commun 2010;401(3):429–34.
[22] ChewN, Tan E, Li L, Lim R. HIV-1 Rat and Rev upregulates osteoclast bone resorption.
J Int AIDS Soc 2014;17(4Suppl 3):19724.
[23] VuMQ,WeintraubN, Rubenstein LZ. Falls in thenursing home: are theypreventable?
J AmMed Dir Assoc 2006;7:S53.
[24] Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised per-
spective of the pathogenesis of osteoporosis. Endocr Rev 2010;31:266.
[25] Khosla S, Melton LJ, Riggs BL. The unitary model for estrogen deﬁciency and the
pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res 2011;26:441.
[26] Borderi M, Gibellinib D, Vescinic F, Crignisb E, Cimattib L, Biagettia C, et al. Metabolic
bone disease on HIV infection. AIDS 2009;23(11):1297–310.
[27] Lopes RF, Ferreira SAGJ, Coeli CM, Farias MLF. Low body mass index and declining
sex steroids explain most age-related bone loss in Brazilian men. Osteoporos Int
2008;20(7):1175–82.
[28] Brincat M, Galea R, Baron YM, Xuereb A. Changes in bone collagen markers and in
bone density in hormone treated and untreated postmenopausal women. Maturitas
1997;27(2):171–7.
[29] Calore EE, Tanaka PY, Perez NM, De Almeida LV. Bone marrow pathology in AIDS.
Pathol Res Pract 2004;200(9):591–7.
[30] Diebold J, Tabbara W, Marche C, Audouin J, Le Tourneau A. Bone marrow changes at
several stages of HIV infection, studied on bonemarrow biopsies in 85 patients. Arch
Anat Cytol Pathol 1991;39(4):137–46.
[31] Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, et al. Altered
clonogenic capability and stromal cell function characterize bone marrow of HIV-
infected subjects with Low CD4+ T cell counts despite viral suppression during
HAART. Clin Infect Dis 2008;46(12):1902–10.
[32] Ercoli L, Sarmati L, Parisi SG, Mancino G, De Santis G, Bonnano E, et al. Human immu-
nodeﬁciency virus infection of human bone marrow stromal myoid cells. Scand J In-
fect Dis 1996;28:335–40.
[33] Gill V, Shattock RJ, Scopes J, Hayes P, Freedman AR, Grifﬁn GE, et al. Human immu-
nodeﬁciency virus infection impairs hemopoiesis in long-term bone marrow
cultures: non reversal by nucleoside analogues. J Infect Dis 1997;176:1510–6.[34] Kulkosky J, BouhamdanM, Geist A, Nunnari G, Phinney DG, Pomerantz RJ. Pathogen-
esis of HIV-1 infection within bone marrow cells. Leuk Lymphoma 2000;37:
497–515.
[35] O’Malley DP, Sen J, Juliar BE, Orazi A. Evaluation of stroma in human immunodeﬁ-
ciency virus/acquired immunodeﬁciency syndrome-affected bonemarrows and cor-
relation with CD4 counts. Arch Pathol Lab Med 2005;129:1137–40.
[36] Steinberg HN, Anderson J, Crumpacker CS, Chatis PA. HIV infection of the BS-1
human stroma cell line: effect on murine hematopoiesis. Virology 1993;193:524.
[37] Gougeon ML, Ledru E, Naora H, Bocchino M, Lecoeur H. HIV, cytokines and pro-
grammed cell death. A subtle interplay. Ann N Y Acad Sci 2000;926:30–45.
[38] Estes JD, Li Q, Reynolds MR, Wietgrefe S, Duan L, Schaker T, et al. Premature induc-
tion of an immunosuppressive regulatory T cell response during acute simian immu-
nodeﬁciency virus infection. J Infect Dis 2006;193:703–12.
[39] Thomson TM, Rettig WJ, Chesa PG, Green SH, Mena AC, Old LJ. Expression of human
nerve growth factor receptor on cells derived from all three germ layers. Exp Cell Res
1988;174:533–9.
[40] Cattoretti G, Schiro R, Orazi A, Soligo D, Colombo MP. Bone marrow stroma in
humans: anti-nerve growth factor receptor antibodies selectively stain reticular
cells in vivo and in vitro. Blood 1993;81:1726–38.
[41] Osborne BM, Guarda LA, Butler JJ. Bone marrow biopsies in patients with the ac-
quired immunodeﬁciency syndrome. Hum Pathol 1984;15(11):1048–53.
[42] Geller SA, Muller R, GreenbergML, Siegal FP. Acquired immunodeﬁciency syndrome.
Distinctive features of bone marrow biopsies. Arch Pathol Lab Med 1985;109:
138–41.
[43] Castella A, Croxson TS, Mildvan D, Witt DH, Zalusky R. The bone marrow in AIDS. A
histologic, hematologic, and microbiologic study. Am J Clin Pathol 1985;84(4):
425–32.
[44] Donald S, Karcher Andra R. Frost: the bone marrow in human immunodeﬁciency
virus (HIV)—related disease. Am J Clin Pathol 1991;95:63–71.
[45] Serrano S, Marinoso ML, Soriano JC, Rubiés-Prat J, Aubia J, Coll J, et al. Bone remod-
eling in human immunodeﬁciency virus-1-infected patients. A histomorphometric
study. Bone 1995;16:185–91.
[46] Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and
osteoporosis: a meta-analytic review. AIDS 2006;20:2165–74.
[47] Calmy A, Chevalley T, Delhumeau C, ToutousTrellu L, Spycher-Elbes R, Ratib O, et al.
Long-term HIV infection and antiretroviral therapy are associated with bone micro-
structure alterations in premenopausal women. Osteoporos Int 2013;24:1843–52.
[48] Kotwal J, Singh V, Kotwal A, Dutta V, Nair V. A study of haematological and bone
marrow changes in symptomatic patients with human immune deﬁciency virus in-
fection with special mention of functional iron deﬁciency, anaemia of critically ill
and haemophagocytic lymphohistiocytosis. Med J Armed Forces India 2013;69(4):
319–25.
[49] Biver E, Calmy A, Delhumeau C, Durosier C, Zawadynski S, Rizzoli R. Microstructural
alterations of trabecular and cortical bone in long-term HIV-infected elderly men on
successful antiretroviral therapy. AIDS [Internet] 2014;28(16):2417–27.
